tiprankstipranks
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
ONCO
Oncopeptides AB
RESEARCH TOOLSreports
Want to see SE:ONCO full AI Analyst Report?

Oncopeptides AB (ONCO) Stock News & Sentiment

10 Followers
Premium
Company Announcements
Oncopeptides Marks Growth Phase as 2025 Annual Report Highlights Pepaxti Momentum
5d ago
Premium
Company Announcements
Oncopeptides Sets May Date and Rules for 2026 AGM Participation
18d ago
Premium
Company Announcements
Oncopeptides Showcases Promising NK-Cell Engager Data for Multiple Myeloma at AACR 2026
20d ago
Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push
Premium
Company Announcements
Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push
1M ago
Oncopeptides Raises SEK 190 Million in Partially Guaranteed Rights Issue
Premium
Company Announcements
Oncopeptides Raises SEK 190 Million in Partially Guaranteed Rights Issue
2M ago
Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany
Premium
Company Announcements
Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany
2M ago
Real-World Data Bolsters Oncopeptides’ Pepaxti as Bridging Therapy in Multiple Myeloma
Premium
Company Announcements
Real-World Data Bolsters Oncopeptides’ Pepaxti as Bridging Therapy in Multiple Myeloma
2M ago
More SE:ONCO News >

ONCO News on the Web

Oncopeptides Sets May Date and Rules for 2026 AGM Participation
TipRanks News
Neutral
Oncopeptides Showcases Promising NK-Cell Engager Data for Multiple Myeloma at AACR 2026
TipRanks News
Bullish
Oncopeptides Boosts Share Capital After Rights Issue to Support Cancer Drug Push
TipRanks News
Bullish
Oncopeptides Raises SEK 190 Million in Partially Guaranteed Rights Issue
TipRanks News
Neutral
Oncopeptides Launches Real-World MARINA Study for Pepaxti in Germany
TipRanks News
Bullish
Real-World Data Bolsters Oncopeptides’ Pepaxti as Bridging Therapy in Multiple Myeloma
TipRanks News
Neutral
Oncopeptides Wins Fast-Track Status for First PDC Trial in Glioblastoma
TipRanks News
Bullish
Oncopeptides AB Balances Growth, Cash Crunch in Earnings
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
SE:ONCO
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:ONCO’s Media Buzz Sentiment?
1 articles about SE:ONCO were published this week. In an average week, 1 articles are published.
    What is SE:ONCO’s weekly average amount of articles?
    In an average week, 1 articles about SE:ONCO are published.
      What is SE:ONCO’s News Sentiment?
      50% of articles about SE:ONCO were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week